ISPOR's Commitment to Payer Engagement
ISPOR Payer Engagement Summit 2020
ISPOR held its first Payer Engagement Summit in 2020. The Summit, entitled “Quality, Access, and Use of Real-World Data (RWD) by Payers: Where Are We Now? Where Do We Want to Be in the Future?,” explored how payers can incorporate RWD into their decision making. One of the biggest challenges payers face today is the impact of innovative, new therapies for diseases with unmet-needs, such as cancer and rare diseases. These novel, high-cost therapies—some that require only 1 or 2 doses—are straining healthcare system budgets, raising affordability and equity issues, and creating a great deal of uncertainty for payers. Payers are addressing this challenge through a variety of approaches, including coverage with evidence development and outcomes-based contracts. RWD is critical to ensuring the success of these agreements. Beyond its use in managed entry agreements, RWD also plays a critical role in augmenting the scientific evidence of medical technologies. The use of RWD can empower payers to make efficient decisions that can reduce wasteful spending, improve patient outcomes, and lead to more sustainable healthcare systems.
Additional Payer Engagement Initiatives
Health Technology Assessment Council
- Provide a platform for regional ISPOR HTA Roundtables to share issues and recommendations
- Provide guidance in the translation and use of outcomes studies as useful information in the health technology assessment and healthcare decision-making processes.
- Address issues and concerns of decision makers globally.
- Assist in the development and implementation of initiatives related to the use of outcomes research information by healthcare decision makers.
Health Technology Assessment Roundtables
ISPOR’s Health Technology Assessment Roundtables provide a platform to advance scientific methods; to facilitate information sharing about the current state of HTA, its development, and its role in optimizing healthcare decisions; and to bridge the gap between technology assessors, private and public payers, regulators, and patients to improve health globally. HTA Roundtables convene annually in Asia Pacific, Europe, Latin America, Middle East and Africa, and North America. The first roundtable was founded in North America in 2006 and was comprised of invited members of pharmacy and therapeutics (P&T) committees in the United States and Canada and expanded over time to the current regional formats.
Health Technology Assessment Central
ISPOR’s Health Technology Assessment Central microsite (HTACentral.org) is a comprehensive repository of resources and tools to support HTA, that helps bridge the gap between health economics and outcomes research (HEOR) and other disciplines that inform HTA and healthcare decisions.